Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas (ECOBASO)

NCT06271603 is registered in ClinicalTrials.gov with Damae Medical as lead sponsor.

NCT NCT06271603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06271603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas (ECOBASO)
Lead sponsor
Damae Medical
Phase
Not applicable
Overall status
Unknown status
Start date
February 26, 2024
Completion date
February 28, 2026
Enrollment
704 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma of the skin